Stay updated with breaking news from 58958410. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Comerica Bank trimmed its holdings in shares of Meridian Bioscience, Inc. (NASDAQ:VIVO – Get Rating) by 10.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,486 shares of the company’s stock after selling 3,722 shares during the period. Comerica Bank owned 0.08% of […]
Virginia Retirement Systems ET AL lessened its stake in shares of Meridian Bioscience, Inc. (NASDAQ:VIVO – Get Rating) by 23.3% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 19,800 shares of the company’s stock after selling 6,000 shares during the period. Virginia Retirement Systems ET AL’s […]
Brokerages predict that Meridian Bioscience, Inc. (NASDAQ:VIVO – Get Rating) will announce sales of $71.65 million for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Meridian Bioscience’s earnings, with estimates ranging from $70.30 million to $73.00 million. Meridian Bioscience posted sales of $63.51 million during the same quarter last year, […]
Wall Street analysts expect Meridian Bioscience, Inc. (NASDAQ:VIVO – Get Rating) to announce $0.23 earnings per share for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Meridian Bioscience’s earnings, with the highest EPS estimate coming in at $0.23 and the lowest estimate coming in at $0.22. Meridian Bioscience reported […]
Meridian Bioscience (NASDAQ:VIVO – Get Rating) updated its FY 2022 earnings guidance on Monday. The company provided EPS guidance of $1.30-$1.40 for the period, compared to the consensus EPS estimate of $1.37. The company issued revenue guidance of $330.00 million-$345.00 million, compared to the consensus revenue estimate of $337.62 million. NASDAQ:VIVO opened at $27.05 on […]